Molecular Weight: 653.65 g/mol
Chemical Structure
Check the
Tazemetostat hydrobromide
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
|
Concentration
Volume
Mass
|
|---|
Batch:
All in vitro solubility values are batch-tested experimental data (non-literature values).
| Solvent | Solubility & Note |
|---|---|
| DMSO |
100 mg/mL
(152.98 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Ethanol | 3 mg/mL |
| Water | Insoluble |
| DMSO |
100 mg/mL
(152.98 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Ethanol | 6 mg/mL |
| Water | Insoluble |
Q: Why does a DMSO stock precipitate in media/saline?
A: It is caused by unheated aqueous media (supersaturation), local solvent shock, or incorrect mixing sequence.
How to fix it?
- Preheat media/saline to 37°C.
- Mix rapidly (pipette/vortex) upon addition.
- For complex mixes, always add the aqueous phase last.
- Re-dissolve minor precipitates with a 37°C water bath and sonication (≤30 min).
| IUPAC Name | N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-3-[ethyl(oxan-4-yl)amino]-2-methyl-5-[4-(morpholin-4-ylmethyl)phenyl]benzamide;hydrobromide | |
|---|---|---|
| CAS Number | 1467052-75-0 | |
| Molecular Formula |
C34H44N4O4.BrH |
|
| Molecular Weight (MW) | 653.65 | |
| InChIKey | UQRICAQPWZSJNF-UHFFFAOYSA-N |
- Tazemetostat hydrobromide Clinical Trials
- Tazemetostat hydrobromide Solubility in DMSO
- Tazemetostat hydrobromide Stock Solution
- Tazemetostat hydrobromide Storage
- Tazemetostat hydrobromide Stability
- Tazemetostat hydrobromide CAS Number
- Tazemetostat hydrobromide Chemical Structure (2D and 3D)
- Tazemetostat hydrobromide SDS｜MSDS
Note: Technical data last updated: Sep 1, 2026.